Journal of Cancer Research and Therapeutics Close
 

Table 2: Incidence of treatment-related adverse events after transarterial chemoembolization/radiofrequency ablation/anlotinib treatment

Table 2: Incidence of treatment-related adverse events after transarterial chemoembolization/radiofrequency ablation/anlotinib treatment